| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $5.2B | $6.9B | $15.6B | $8.0B | $0.2B |
| Cost of Revenue | $4.0B | $4.7B | $6.5B | $14.9B | $7.3B | $2.4B |
| Gross Profit | $0.3B | $0.4B | $0.5B | $0.7B | $0.7B | $0.0B |
| R&D Expense | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $-0.3B | $-0.3B | $-0.4B | $-0.9B | $-0.6B | $-0.2B |
| Net Income | $-1.3B | $-0.4B | $-0.3B | $-1.4B | $-0.7B | $-0.3B |
| EPS (Basic) | $-1.70 | $-0.56 | $-0.42 | $-2.16 | $-1.12 | $-0.49 |
| EPS (Diluted) | $-1.70 | $-0.56 | $-0.42 | $-2.16 | $-1.12 | $-0.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $2.4B | $3.1B | $3.6B | $6.6B | $9.5B | $2.2B |
| Current Assets | $2.3B | $3.0B | $3.4B | $6.5B | $9.3B | $2.1B |
| Cash & Equivalents | $1.0B | $0.7B | $1.0B | $1.1B | $1.7B | $1.4B |
| Total Liabilities | $1.4B | $2.4B | $2.6B | $5.5B | $7.3B | $0.6B |
| Current Liabilities | $0.3B | $0.5B | $0.1B | $1.5B | $4.4B | $0.4B |
| Stockholders' Equity | $1.0B | $0.7B | $1.0B | $1.1B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $-0.6B | $2.3B | $0.7B | $-5.8B | $0.7B |
| Investing Cash Flow | $-0.0B | $0.0B | $0.0B | $0.2B | $-0.5B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.5B | $-0.2B | $-2.6B | $-1.8B | $7.3B | $0.2B |